PREVALENCE OF ADULT-ONSET IDDM IN THE US POPULATION

被引:46
作者
HARRIS, MI
ROBBINS, DC
机构
[1] NIDDKD, NATL DIABET DATA GRP, BETHESDA, MD USA
[2] MEDLANTIC RES INST, WASHINGTON, DC USA
关键词
D O I
10.2337/diacare.17.11.1337
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To investigate the prevalence of adult-onset insulin-dependent diabetes mellitus (IDDM) in a nationally representative sample of adults 30-74 years of age. Although it is a widely held belief that onset of IDDM in adults is rare, there are few objective data to support this. Adult-onset IDDM may represent a disease that is biologically distinct from youth-onset IDDM, and it would be important to distinguish these two entities. RESEARCH DESIGN AND METHODS - The Second National Health and Nutrition Examination Survey (NHANES II) contained a national probability sample of 12,102 subjects 30-74 years of age in the U.S. population. All subjects with diabetes diagnosed by a physician before the survey were identified. Cases of IDDM defined by age at diagnosis greater than or equal to 30 years, continuous or nearly continuous insulin treatment since diagnosis of diabetes, and relative body weight less than or equal to 125 were classified as adult-onset IDDM. RESULTS- Subjects with adult-onset IDDM represented 0.30% of the U.S. population 30-74 years of age and 7.4% of all diabetic patients diagnosed at 30-74 years of age. CONCLUSIONS - These data indicate that onset of IDDM in adults is uncommon. Given the limitations of the survey instrument, subclinical or slowly progressive IDDM (as distinguished from non-insulin-dependent diabetes mellitus with progressive loss of beta-cell function) would not have been detected, and these would constitute additional cases of adult-onset IDDM. However, the data suggest that a very large population base would be required to identify sufficient numbers of adult-onset IDDM cases for study of the etiology and pathogenesis of this disease.
引用
收藏
页码:1337 / 1340
页数:4
相关论文
共 26 条
[1]   C-PEPTIDE RESPONSE TO MEAL CHALLENGE IN NONDIABETIC AND DIABETIC ADULTS LIVING IN WADENA, MINNESOTA [J].
BUSHHOUSE, SA ;
GOETZ, FC ;
JACOBS, DR ;
BENDER, AP ;
FRENCH, LR ;
OESTREICH, PG ;
GEISSER, MS .
DIABETES CARE, 1992, 15 (10) :1335-1347
[2]  
DCCT Res Grp, 1988, DIABETES CARE, V11, P567
[3]   FASTING PLASMA C-PEPTIDE, GLUCAGON STIMULATED PLASMA C-PEPTIDE, AND URINARY C-PEPTIDE IN RELATION TO CLINICAL TYPE OF DIABETES [J].
GJESSING, HJ ;
MATZEN, LE ;
FABER, OK ;
FROLAND, A .
DIABETOLOGIA, 1989, 32 (05) :305-311
[4]   ORGAN-SPECIFIC AUTOIMMUNITY AND HLA-DR ANTIGENS AS MARKERS FOR BETA-CELL DESTRUCTION IN PATIENTS WITH TYPE-II DIABETES [J].
GROOP, L ;
MIETTINEN, A ;
GROOP, PH ;
MERI, S ;
KOSKIMIES, S ;
BOTTAZZO, GF .
DIABETES, 1988, 37 (01) :99-103
[5]   ISLET CELL ANTIBODIES IDENTIFY LATENT TYPE-I DIABETES IN PATIENTS AGED 35-75 YEARS AT DIAGNOSIS [J].
GROOP, LC ;
BOTTAZZO, GF ;
DONIACH, D .
DIABETES, 1986, 35 (02) :237-241
[6]   PREVALENCE OF DIABETES AND IMPAIRED GLUCOSE-TOLERANCE AND PLASMA-GLUCOSE LEVELS IN UNITED-STATES POPULATION AGED 20-74 YR [J].
HARRIS, MI ;
HADDEN, WC ;
KNOWLER, WC ;
BENNETT, PH .
DIABETES, 1987, 36 (04) :523-534
[7]   PANCREATIC ISLET-CELL ANTIBODIES IN DIABETES-MELLITUS CORRELATED WITH DURATION AND TYPE OF DIABETES, COEXISTENT AUTOIMMUNE-DISEASE, AND HLA TYPE [J].
IRVINE, WJ ;
MCCALLUM, CJ ;
GRAY, RS ;
CAMPBELL, CJ ;
DUNCAN, LJP ;
FARQUHAR, JW ;
VAUGHAN, H ;
MORRIS, PJ .
DIABETES, 1977, 26 (02) :138-147
[8]   A COMPARISON OF CHILDHOOD AND ADULT TYPE-I DIABETES-MELLITUS [J].
KARJALAINEN, J ;
SALMELA, P ;
ILONEN, J ;
SURCEL, HM ;
KNIP, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (14) :881-886
[9]   C-PEPTIDE MEASUREMENT IN THE DIFFERENTIATION OF TYPE-1 (INSULIN-DEPENDENT) AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
KATZEFF, HL ;
SAVAGE, PJ ;
BARCLAYWHITE, B ;
NAGULESPARAN, M ;
BENNETT, PH .
DIABETOLOGIA, 1985, 28 (05) :264-268
[10]  
LAAKSO M, 1987, DIABETES RES CLIN EX, V4, P95